Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors

Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors

Background: Programmed cell death receptor ligand 1 (PD-L1) inhibitors are immune checkpoint inhibitors (ICIs) with a side effect profile that may differ from other classes of ICIs such as those directed against cytotoxic T-lymphocyte−associated protein 4 (CTLA-4) and programmed cell death 1 recepto...

Full description

Bibliographic Details
Main Authors: Harish Seethapathy, Sophia Zhao, Ian A. Strohbehn, Meghan Lee, Donald F. Chute, Halla Bates, Gabriel E. Molina, Leyre Zubiri, Shruti Gupta, Shveta Motwani, David E. Leaf, Ryan J. Sullivan, Osama Rahma, Kimberly G. Blumenthal, Alexandra-Chloe Villani, Kerry L. Reynolds, Meghan E. Sise
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Kidney International Reports
Subjects:
acute interstitial nephritis
acute kidney injury
immune checkpoint inhibitor
immune-related adverse events
PD-L1 inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024920313760

Internet

http://www.sciencedirect.com/science/article/pii/S2468024920313760

Similar Items